Lantheus Holdings (LNTH) Change in Cash (2014 - 2026)
Lantheus Holdings' (LNTH) quarterly Change in Cash came in at $139.5 million in Q1 2026, up 442.09% year-on-year from $25.7 million in Q1 2025, and up 709.62% on a QoQ basis from -$22.9 million in Q4 2025.
Lantheus Holdings (LNTH) Change in Cash (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 13 years of Change in Cash data on file, last reported at $139.5 million in Q1 2026.
- On a quarterly basis, Change in Cash rose 442.09% year-over-year to $139.5 million in Q1 2026; TTM through Mar 2026 was -$439.9 million, a 299.7% decrease from a year earlier, with the FY2025 full-year figure at -$553.7 million, down 377.94% from the prior year.
- Change in Cash for Q1 2026 stood at $139.5 million, up from -$22.9 million in the prior quarter.
- Over the last five years, Change in Cash for LNTH reached as high as $200.1 million in Q3 2023 and fell as low as -$313.6 million in Q3 2025.
- Historically, Change in Cash has averaged $23.5 million across 5 years, with a median of $46.4 million in 2024.
- Across the five-year window, Change in Cash surged 341188.0% in 2022 and plunged 726.97% in 2025, its largest moves.
- Year by year, Change in Cash stood at $158.4 million in 2022, then sank by 37.16% to $99.5 million in 2023, then tumbled by 53.35% to $46.4 million in 2024, then sank by 149.27% to -$22.9 million in 2025, then soared by 709.62% to $139.5 million in 2026.
- Per Business Quant data, the three most recent Change in Cash figures were $139.5 million in Q1 2026, -$22.9 million in Q4 2025, and -$313.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 185.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -509.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -388.85 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 457.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -117.00 Mn |
| 10 | Lantheus Holdings | 6.72 Bn | 6.22 Bn | 230.92 Mn | 139.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 139.47 Mn |
| Dec 31, 2025 | -22.88 Mn |
| Sep 30, 2025 | -313.56 Mn |
| Jun 30, 2025 | -242.95 Mn |
| Mar 31, 2025 | 25.73 Mn |
| Dec 31, 2024 | 46.44 Mn |
| Sep 30, 2024 | 109.38 Mn |
| Jun 30, 2024 | 38.75 Mn |
| Mar 31, 2024 | 4.63 Mn |
| Dec 31, 2023 | 99.54 Mn |
| Sep 30, 2023 | 200.07 Mn |
| Jun 30, 2023 | -56.78 Mn |
| Mar 31, 2023 | 55.22 Mn |
| Dec 31, 2022 | 158.40 Mn |
| Sep 30, 2022 | 85.27 Mn |
| Jun 30, 2022 | 66.07 Mn |
| Mar 31, 2022 | 6.85 Mn |
| Dec 31, 2021 | 7.03 Mn |
| Sep 30, 2021 | -25,000.00 |
| Jun 30, 2021 | 22.64 Mn |